138030-54-3

Usage

Uses

Used in Pharmaceutical Industry:
Ethyl 1-((pyridin-4-yl)methyl) piperidine-4-carboxylate is used as a building block for the synthesis of various pharmaceuticals and bioactive molecules. Its unique structure and properties make it a valuable component in the development of new drugs and therapeutic agents.
Used in Medicinal Chemistry Research:
Ethyl 1-((pyridin-4-yl)methyl) piperidine-4-carboxylate is used as a research compound in medicinal chemistry. Its antinociceptive effects have been reported in experimental studies, indicating its potential as a starting point for the development of analgesic drugs.
Used in Organic Synthesis:
Ethyl 1-((pyridin-4-yl)methyl) piperidine-4-carboxylate is used as a versatile chemical in organic synthesis. Its unique structure allows it to be incorporated into a wide range of chemical reactions, making it a valuable tool for the synthesis of complex organic molecules.

InChI:InChI=1/C14H20N2O2/c1-2-18-14(17)13-5-9-16(10-6-13)11-12-3-7-15-8-4-12/h3-4,7-8,13H,2,5-6,9-11H2,1H3

Upstream product

• 872-85-5 pyridine-4-carbaldehyde 
• 1126-09-6 4-carbethoxypiperidine 

Downstream Products

• 1215120-87-8 C₂₅H₃₁N₅O₂ 
• 1246290-34-5 C₂₄H₂₉N₃O₂ 
• 1246290-33-4 C₂₄H₃₁N₃O₂ 
• 460092-58-4 C₂₃H₃₀N₄O 
• 1246290-30-1 C₂₂H₂₈N₄O 
• 1246290-31-2 C₂₂H₃₄N₄O 

Relevant academic research and scientific papers

The synthesis and structure-activity relationship of 4-benzimidazolyl- piperidinylcarbonyl-piperidine analogs as histamine H3 antagonists

A structure-activity relationship study of the lead piperazinylcarbonylpiperidine compound 3 resulted in the identification of 4-benzimidazolyl-piperidinylcarbonyl-piperidine 6h as a histamine-3 (H 3) receptor antagonist. Additional optimizatio

PIPERIDINE DERIVATIVES AND METHODS OF USE THEREOF

The present invention relates to Compounds of Formula (I), compositions comprising the compounds, and methods of using the compounds to treat or prevent pain, diabetes, a diabetic complication, impaired glucose tolerance (IGT) or impaired fasting glucose (IFG) in a patient.

1-(4-PIPERIDINYL) BENZIMIDAZOLONES AS HISTAMINE H3 ANTAGONISTS

Disclosed are histamine H3 antagonists of the formula (I) wherein R1 is benzimidazolone derivative, M1 and M2 are optionally substituted carbon or nitrogen, R2 includes optionally substituted aryl or heteroaryl, and the remaining variables are as defined

Reductive amination of piperidines with aldehydes using borane-pyridine

Borane-pyridine complex (BAP) was found to be an excellent replacement for NaCNBH3 in the Borch reduction. Assorted aromatic, heterocyclic and aliphatic aldehydes were reacted with various substituted piperidines using standardized conditions.